We are live on ! Find out more
ANGO icon

AngioDynamics

120 hedge funds and large institutions have $366M invested in AngioDynamics in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 54 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 25

21% more capital invested

Capital invested by funds: $302M → $366M (+$64.1M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

1% less funds holding

Funds holding: 121120 (-1)

Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
3.2%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
54
Reduced
25
Closed
10
Calls
$291K
Puts
Net Calls
+$291K
Net Calls Change
-$1.13M
Name Holding Trade Value Shares
Change
Change in
Stake
First Trust Advisors
126
First Trust Advisors
Illinois
-$407K -33,099 Closed
GC
127
Globeflex Capital
California
-$330K -26,822 Closed
SBH
128
Segall Bryant & Hamill
Illinois
-$234K -19,070 Closed
Balyasny Asset Management
129
Balyasny Asset Management
Illinois
-$184K -15,000 Closed
BJ
130
BlackRock Japan
Japan
-$19K -1,518 Closed

ANGO Hedge Fund Activity: Q2 2016 in Review

120 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2016, worth a combined $366M — up 21% from $302M a quarter earlier.

Fund positioning in ANGO was balanced in Q2 2016: 10 funds opened new positions, 10 closed out, 54 added to existing stakes and 25 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $13.9M. The largest seller was First Light Asset Management, exiting entirely with an estimated $3.36M sold.

  • 120 institutional investors held AngioDynamics (ANGO) as of Q2 2016, down from 121 in Q1 2016.
  • Funds reported $366M of AngioDynamics stock for Q2 2016, up 21% quarter-over-quarter.
  • 10 funds opened new AngioDynamics positions in Q2 2016 and 10 closed out, a net change of 0 holders.
  • The largest AngioDynamics buyer in Q2 2016 was Broadfin Capital, an estimated $13.9M added.
  • The largest AngioDynamics seller in Q2 2016 was First Light Asset Management, an estimated $3.36M sold.

Based on aggregated 13F filings for Q2 2016.